non metastatic trang 3 tải miễn phí từ TAILIEUCHUNG

"non metastatic" trang 3 - tải miễn phí từ Tailieuchung

báo cáo khoa học:

báo cáo khoa học: " Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma"

5 37 0

báo cáo khoa học:

báo cáo khoa học: "Pulmonary sclerosing hemangioma in a 21-year-old male with metastatic hereditary non-polyposis colorectal cancer: Report of a case"

6 52 0

Results of antiandrogen and biphosphonate therapy in treatment of bone metastatic prostate cancer in 108 Military Central Hospital

Results of antiandrogen and biphosphonate therapy in treatment of bone metastatic prostate cancer in 108 Military Central Hospital

8 51 0

Atezolizumab plus modified docetaxelcisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: A randomized, non-comparative phase II SCARCE GERCOR trial

Atezolizumab plus modified docetaxelcisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: A randomized, non-comparative phase II SCARCE GERCOR trial

11 77 0

Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials

Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials

17 72 0

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

11 55 1

Prospective study of oncologic outcomes after laparoscopic modified complete mesocolic excision for non-metastatic right colon cancer (PIONEER study): Study protocol of a multicentre single-arm trial

Prospective study of oncologic outcomes after laparoscopic modified complete mesocolic excision for non-metastatic right colon cancer (PIONEER study): Study protocol of a multicentre single-arm trial

10 64 1

Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: A comparative study

Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: A comparative study

8 42 1

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma

16 58 1

Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: A case report

Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: A case report

6 32 1

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: Study protocol for a randomized controlled trial

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: Study protocol for a randomized controlled trial

7 41 1

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial

10 24 1

Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer

Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer

10 43 1

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations

11 51 1

Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study

Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study

9 44 1

Stage of breast cancer at diagnosis in New Zealand: Impacts of socio-demographic factors, breast cancer screening and biology

Stage of breast cancer at diagnosis in New Zealand: Impacts of socio-demographic factors, breast cancer screening and biology

9 57 1

Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma

Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma

9 45 1

Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study

Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study

8 31 1

Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: A population-based analysis

Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: A population-based analysis

11 52 1

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer

7 19 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.